Hills Bank & Trust Co - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Hills Bank & Trust Co ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2022$155
-99.9%
3,036
-4.4%
0.02%
-8.0%
Q3 2022$171,000
-25.3%
3,177
-10.9%
0.02%
-32.4%
Q2 2022$229,000
-32.0%
3,567
-17.9%
0.04%
-22.9%
Q1 2022$337,000
-12.0%
4,347
-2.5%
0.05%
-9.4%
Q4 2021$383,000
+2.7%
4,460
-3.9%
0.05%
-5.4%
Q3 2021$373,000
+1.4%
4,642
+1.6%
0.06%0.0%
Q2 2021$368,000
-6.1%
4,567
-1.6%
0.06%
-12.5%
Q1 2021$392,000
-6.4%
4,642
-11.2%
0.06%
-12.3%
Q4 2020$419,000
-5.2%
5,228
-4.9%
0.07%
-15.1%
Q3 2020$442,000
-27.4%
5,498
-22.3%
0.09%
-33.3%
Q2 2020$609,000
+2.9%
7,073
-3.1%
0.13%
-25.9%
Q1 2020$592,000
-5.6%
7,298
-2.6%
0.17%
+17.6%
Q4 2019$627,000
-6.3%
7,493
-2.1%
0.15%
-12.4%
Q3 2019$669,000
+5.0%
7,653
-1.6%
0.17%
+2.4%
Q2 2019$637,000
-5.1%
7,778
-5.8%
0.16%
-8.8%
Q1 2019$671,000
+13.5%
8,253
-8.1%
0.18%
-1.1%
Q4 2018$591,000
-19.3%
8,976
-5.4%
0.18%
-7.1%
Q3 2018$732,000
+2.4%
9,492
-1.9%
0.20%
-4.4%
Q2 2018$715,000
+2.3%
9,675
-10.0%
0.21%
-2.4%
Q1 2018$699,000
-4.9%
10,746
-5.5%
0.21%
-1.9%
Q4 2017$735,000
+0.3%
11,374
-2.5%
0.22%
-6.5%
Q3 2017$733,000
+0.3%
11,671
-3.3%
0.23%
-3.0%
Q2 2017$731,000
+16.0%
12,071
-0.6%
0.24%
+10.7%
Q1 2017$630,000
+21.2%
12,146
+3.5%
0.21%
+16.9%
Q4 2016$520,000
+4.2%
11,739
+11.9%
0.18%
+1.7%
Q3 2016$499,000
+22.3%
10,489
+16.2%
0.18%
+20.0%
Q2 2016$408,000
+31.2%
9,024
+19.1%
0.15%
+30.4%
Q1 2016$311,0007,5740.12%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders